PL EN


Preferences help
enabled [disable] Abstract
Number of results
2018 | 23 | 3 | 128-132
Article title

Choroby alergiczne oka u dzieci z punktu widzenia lekarza praktyka

Content
Title variants
EN
Allergic diseases of the eye in children from the clinician’s practical point of view
Languages of publication
RU PL
Abstracts
EN
Allergic diseases of eye in children are one of the most common chronic diseases in childhood and often present difficulties in daily clinical practice. The incidence of allergic eye diseases is estimated to be 15- 20% in the general population, and visits related to them encounter for up to 40-60% among patients attending allergy clinics. The peak incidence is at school age around 10 years old. The allergic eye diseases do not always coexist with symptoms of other allergic diseases such as allergic rhinitis (90%). The purpose of this review is to present the therapeutic algorithms for children with symptoms of allergic diseases of eye on the basis of current literature from a practical point of view. It presents tips for allergist and pediatricians on diagnosing allergic eye disorders. In accordance with the guidelines, local antihistaminic medications or mast-cell stabilizers are recommended as first-line treatment due to their strong local anti-itch properties. Immunotherapy seems to be an advantageous alternative to treatment of allergic eye diseases in children.
PL
Choroby alergiczne oka u dzieci należą do jednych z najczęściej wystę- pujących chorób przewlekłych i są częstym problemem w codziennej praktyce pediatrycznej. Częstość występowania chorób alergicznych oczu jest szacowana na 15-20% populacji światowej i stanowi 40-60% pacjentów poradni alergologicznych. Najczęściej u dzieci objawy występują w wieku szkolnym, ze szczytem występowania w 10 r.ż. Objawy oczne nie zawsze występują z objawami innych chorób alergicznych, przy czym najczęściej współwystępują z alergicznym zapaleniem nosa (90%). Celem doniesienia jest przedstawienie algorytmów terapeutycznych dla dzieci z objawami alergii ocznej w oparciu o aktualną literaturę z punktu widzenia codziennej praktyki lekarskiej. Artykuł zawiera wskazówki dla alergologów, pediatrów w zakresie rozpoznawania cech klinicznych alergicznego zapalenia spojówek (AC). Zgodnie z zaleceniami miejscowe leki antyhistaminowe oraz stabilizujące mastocyty powinny być stosowane w terapii 1-go rzutu z uwagi na ich silne miejscowe działanie p/świądowe. Immunoterapia SCID wydaje się być korzystną alternatywą leczenia alergii oka u dzieci.
Discipline
Publisher

Year
Volume
23
Issue
3
Pages
128-132
Physical description
Contributors
  • Katedra i Oddział Kliniczny Pediatrii w Bytomiu Wydział Nauk o Zdrowiu w Katowicach Śląskiego Uniwersytetu Medycznego w Katowicach
References
  • 1. Fudjishima H, Ohashi Y, Takamura E. Efficacy of epinastine hydrochloride ophtalmic solution in allergic conjunctivitis bt conjuctival cedar pollen allergen challenge. Ann Allergy Asthma Immunol 2014; 113: 471-81.
  • 2. Petricek I, Prost M, Popova A. The differential diagnosis of red eye: a survey of medical practitioners from Eastern Europe and the Middle East. Ophthalmologica 2006; 220: 229-301.
  • 3. La Rosa M, Lionetti E, Reibaldi M, et al. Allergic conjunctivitis: A comprehensive review of the literature. Ital Pediatr 2013; 9: 18.
  • 4. Bielory I, Friedlaender MH. Allergic conjunctivitis. Immunol Allergy Clin North Am 2008; 28: 43-58.
  • 5. Rosario N, Bielory L. Epidemiology of allergic conjunctivitis. Curr Opin Allergy Clin Immunol 2011; 11: 471-5.
  • 6. Leonardi A. Allergy and allergic mediators in tears. Exp Eye Res 2013; 117: 106-17.
  • 7. Miraldi Utz V, Kaufman AR. Allergic eye disease. Pediatr North Am 2014; 61: 607-20.
  • 8. Bielory L, Mongia A. Current opinion of immunotherapy for ocular allergy. Curr Opin Allergy Clin Immunol 2002; 2: 447-52.
  • 9. Ridolo E, Montagni M, Caminati M, et al. Emerging drugs for allergic conjunctivitis. Expert Opin Emerg Drugs 2014; 19: 291-302.
  • 10. Bremond-Gignac D, Nischal KK, Mortemousque B, et al. Atopic keratoconjunctivitis in children: Clinical features and diagnosis. Ophtalmology 2016; 123: 435-7.
  • 11. Abelson MB, Granet D. Ocular allergy in pediatric practice. Curr Allergy Asthma Rep 2006; 6: 306-11.
  • 12. Bielory BP, O'Brien TP, Bielory L. Management of seasonal allergic conjunctivitis: guide to therapy. Acta Ophthalmol 2012; 90: 399- 407.
  • 13. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinits and its impact on Asthma (ARIA) guidelines: 2010 - revision. J Allergy Clin Immunol 2010; 126: 466-76.
  • 14. Wingard JB, Mah FS. Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis. Clin Ophthalmol 2011; 5: 201-7.
  • 15. Berger W, Abelson MB, Comes PJ, et al. Effect of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life on patients with allergic rhinitis using systemic or nasal therapy. Ann Allergy Asthma Immunol 2005; 95: 361-71.
  • 16. Petersen KD, Kronborg C, Gyrd-Hansen DI, et al. Quality of life in rhinoconjunctivitis assessed with genetic and disease-specific questionnaires. Allergy 2008; 63: 284-91.
  • 17. Civelek E, Yavuz ST, Boz AB, et al. Epidemiology and burden of rhinitis and rhinoconjunctivitis in 9- to 11-year-old children. Am J Rhinol Allergy 2010; 24: 364-70.
  • 18. Friedlaender MH. Ocular allergy. Curr Opin Allergy Clin Immunol 2011; 11: 477-82.
  • 19. Gradman J , Wolthers OD. Allergic conjunctivitis in children with asthma, rhinitis and eczema in a secondary outpatient clinic. Pediatr Allergy Immunol 2006; 17: 524-6.
  • 20. Suzuki S, Goto E, Dogro M, et al. Tear film lipid layer alterations in allergic conjunctivitis. Corneq 2006; 25: 277-80.
  • 21. Bielory L, Meltzer EO, Nichols KK, et al. An algorithm for the management of allergic conjunctivitis. Allergy Asthma Proc 2013; 34: 408-20.
  • 22. Bielory L. Ocular allergy. Mt Sinai J Med 2011; 78: 740-58.
  • 23. Brookes JL, Khaw PT. Steroid response in children. Clin Experiment Ophthalmol 2005; 33: 229-30.
  • 24. Lam DS, Fan DS, Ng JS, et al. Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial. Clin Experiment Ophthalmol 2005; 33: 252-8.
  • 25. Kaur S, Dhiman I, Kaushik S. Outcome of ocular steroid hypersensitive response in children. J Glaucoma 2015; 25: 343-7.
  • 26. Dinowitz M, Rescigno R, Bielory L. Ocular allergic diseases: Differential diagnosis, examination techniques and testing. Clin Allergy Immunol 2000; 15: 127-50.
  • 27. Optometrists Co. Seasonal allergic conjunctivitis (SAC, hay fever conjunctivitis); perennial allergic conjunctivitis (PAC): College of Optometrists, 2010. Available at: www.college-optometrists.org/ en/utilities/document-summary.cfm/docid/281E5349-E39C-4E- 81-AEBC3B57F1379BF5. Last accessed: September, 2016.
  • 28. Abelson MB, Spitalny L. Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity. Am J Ophthalmol 1998; 125: 797-804.
  • 29. Calderon AA, Penaglos M, Sheik A, et al. Sublingual immunotherapy for allergic conjunctivitis. Cohrane systematic review and meta- -analysis. Clin Exp Allergy 2011; 41: 1263-72.
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-fd6bc6c2-6401-4caa-a3a3-316f38c8edc2
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.